[111In-DOTA]LTT-SS28, a First Pansomatostatin Radioligand for in Vivo Targeting of Somatostatin Receptor-Positive Tumors-Reference-Cited by-同舟云学术

[111In-DOTA]LTT-SS28, a First Pansomatostatin Radioligand for in Vivo Targeting of Somatostatin Receptor-Positive Tumors

Published:2014-07-23 Issue:15 Volume:57 Page:6564-6571
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Maina Theodosia¹,Cescato Renzo²,Waser Beatrice²,Tatsi Aikaterini¹,Kaloudi Aikaterini¹,Krenning Eric P.³,de Jong Marion³⁴,Nock Berthold A.¹,Reubi Jean Claude²

Affiliation:

1. Molecular Radiopharmacy, INRASTES, National Center for Scientific Research “Demokritos”, GR-153 10 Athens, Greece

2. Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, CH-3010 Berne, Switzerland

3. Department of Nuclear Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands

4. Department of Radiology, Erasmus MC, 3015 CE Rotterdam, The Netherlands

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm500581d

Reference40 articles.

1. Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

2. Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy

3. Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

4. Octreotide

5. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiolabeled Somatostatin Analogs for Cancer Imaging;Seminars in Nuclear Medicine;2024-08

2. Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability;Pharmaceutics;2024-03-13

3. Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [111In]In-Radioligands: Synthesis and Preclinical Profile;International Journal of Molecular Sciences;2024-02-05

4. Theranostic Radiopeptides in Nuclear Oncology: Design, Preclinical Screening, and Clinical Translation;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024

5. [111In]In/[177Lu]Lu-AAZTA5-LM4 SST2R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results;Pharmaceutics;2023-02-26